This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Human CD253:Low Endotoxin
catalog :
MCA2144ELGA
quantity :
0.1 mg
price :
479 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
2E5
reactivity :
human
application :
western blot, flow cytometry
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA2144ELGA
Description :
MOUSE ANTI HUMAN CD253:Low Endotoxin
Specificity :
CD253
TargetSpecies :
Human
Host :
Mouse
Format :
Low Endotoxin
Isotypes :
IgG1
Applications :
F, FN, WB
ApplicationTypes :
Flow Cytometry, Western Blotting, Functional Assays
Clone :
2E5
Quantity :
0.1 mg
QuantityValue :
0.1
QuantityType :
mg
GOAccessions :
GO:0007165, GO:0005887, GO:0005125, GO:0005164, GO:0046872, GO:0005615, GO:0005625, GO:0006919, GO:0006955, GO:0007267, GO:0008624, GO:0008633, GO:0043123
GOTerms :
activation of I-kappaB kinase/NF-kappaB cascade, autocrine activity, caspase activation, cell-cell signalling, GO:0023033, heavy metal binding, induction of pro-apoptotic gene products, intercellular space, metal binding, paracrine activity, signaling cascade, signaling pathway, signalling cascade, signalling pathway, soluble, stimulation of I-kappaB kinase/NF-kappaB cascade, TNF receptor binding, tumor necrosis factor, tumor necrosis factor receptor ligand, up regulation of I-kappaB kinase/NF-kappaB cascade, up-regulation of I-kappaB kinase/NF-kappaB cascade, upregulation of I-kappaB kinase/NF-kappaB cascade
UniprotAccessions :
P50591
Gene :
TNFSF10
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8743
PublishedSynonyms :
TRAIL
EntityFormats :
Low Endotoxin
UNSPSC :
12352203
Concentration :
IgG concentration 1.0 mg/ml
ProductForm :
Purified IgG - liquid
PriceDKK :
3565
PrimarySecondary :
Primary
PriceGBP :
340
PriceEUR :
479
PriceUSD :
479 USD
PriceCHF :
561
PriceSEK :
4775
PriceNOK :
4744
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments